Oculmirt №30 tab

Parapharmaceutical product
,,ოკულმირტი’’
,,OOCULMYRT’’
Tablets
Instructions for use

Composition:
Active ingredient:
Thick bilberry extract – 350 mg.
(Extractum Myrtilli spissum)
Inactive ingredients: Starch, magnesium carbonate, calcium stearate, talc.
Description: Bluish-black tablets with a slightly acidic taste and inclusions of variously colored speckles.
Pharmacological group: Antioxidant agent.
Pharmacological action: Bilberry extract possesses antioxidant, antimicrobial, and anti-inflammatory properties. It reduces capillary fragility and increases capillary elasticity (which is essential for collagen synthesis, affecting the elasticity of blood vessel walls, and stimulates mucopolysaccharide synthesis); improves the elasticity of cell membranes, stabilizes phospholipids in endothelial cells, and inhibits platelet aggregation.
It improves the condition of ocular capillaries and the blood supply to the ocular tissues, promotes regeneration of the retinal pigment rhodopsin, increases its sensitivity to changes in light intensity, and improves visual adaptation to darkness and visual acuity. It provides natural protection of ocular structures against the aging process through its antioxidant activity, helps normalize metabolic processes in ocular tissues, neutralizes free radicals, and protects ocular tissues from their damaging effects. It enhances the eye’s natural ability to absorb and neutralize aggressive radiation (the visible blue portion of the light spectrum, ultraviolet, and ionizing radiation) and protects the eyes from fatigue and irritation during prolonged exposure to artificial lighting.
It adsorbs intestinal toxins and forms a dense protein film on the superficial layer of the intestinal mucosa, which protects tissue cells from various irritants, thereby reducing pain and inflammatory processes, slowing intestinal peristalsis, and improving absorption. It also reduces dyspeptic symptoms caused by increased fermentation and putrefaction processes and possesses an astringent effect.
Pharmacokinetics: Following oral administration, the anthocyanosides contained in “Oculmyrt” are rapidly absorbed from the gastrointestinal tract and distributed throughout the tissues. They are excreted via the urinary and biliary routes according to a three-phase pharmacokinetic pattern.
Indications: Used as an adjunctive medicinal product in complex therapy for:
· retinal dystrophic changes of various etiologies;
· myopia (especially in schoolchildren);
· impaired visual adaptation to darkness;
· eye fatigue syndrome;
· prevention of age-related changes in ocular structures;
· prevention of eye diseases in patients with diabetes mellitus and arterial hypertension;
· general restorative use at the first signs of eye disorders and for the prevention of certain occupational conditions associated with excessive radiation exposure (actors, television personnel, individuals working for prolonged periods at computers, radiologists, mountaineers, skiers, etc.);
· gastrointestinal diseases of various etiologies, including digestive disorders, dyspepsia, enterocolitis, and gastric and duodenal ulcer disease.
Contraindications:
Hypersensitivity to any of the components of the medicinal product, constipation, nephrolithiasis, oxaluria.
Method of administration and dosage: Orally.
Children aged 3 to 6 years: one tablet twice daily after meals;
Children aged 6 to 12 years: one tablet 3 times daily after meals;
Adults and children over 12 years of age: 1–2 tablets 3 times daily after meals.
The therapeutic effect develops during the first three weeks after initiation of treatment and becomes more pronounced with regular administration of the medicinal product.
When used to improve vision, the duration of treatment is 1–2 months. Repeated courses of treatment are recommended;
For prophylactic purposes, the medicinal product may be taken as a 2-month course twice a year.
In other cases, the medicinal product should be taken according to the indications.
Overdose:
No cases of overdose have been reported.
Pregnancy and lactation:
No data are available regarding the use of the medicinal product during pregnancy and lactation.
Adverse reactions:
No adverse reactions have been reported when the medicinal product is used at the recommended doses. In rare cases, allergic reactions may occur.
Effects on drivers and personnel operating potentially hazardous machinery and equipment: No effect.
Interaction with other medicinal products: Not studied.
Packaging: Primary packaging: 10 tablets per blister.
Secondary packaging: 3 blisters in a cardboard box together with the package leaflet.
Storage: Store in a dry place, protected from light and out of the reach of children, at room temperature.
The medicinal product must not be used after the expiry date or if any defects are detected during visual inspection!
Shelf life: 3 years.
Dispensing conditions: Pharmaceutical product Group III, available without a prescription.
Manufacturer: LLC “Neopharm”.

Georgia. Tbilisi. David Agmashenebeli Avenue, 12th km.
Tel/Fax: +995 (032) 259-64-46, 259-57-90.